TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) — Reunion Neuroscience Inc. (formerly, Field Trip Health Ltd., the “ Company” or “Reunion”), a global leader in the discovery and development of innovative of psychedelic-inspired therapeutics for improved mental health outcomes, is pleased to announce that its common shares (the “Shares“) will commence trading on the Toronto Stock Exchange (“TSX”) under the…
